Advanced Viral Research Corp./Dicke III SC 13G


	OMB APPROVAL
	OMB Number: 3235-0145
	Expires: February 28, 2006
	Estimated average burden hours per response...11

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13G

Under the Securities Exchange Act of 1934
(Amendment No. )*

ADVANCED VIRAL RESEARCH CORP.

(Name of Issuer)

Common Shares

(Title of Class of Securities)

007928104

(CUSIP Number)

December 31, 2005

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

o Rule 13d-1(b)

o Rule 13d-1(c)

þ Rule 13d-1(d)

* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Page 1 of 5 Pages


CUSIP No.		007928104		Page 2 of 5 Pages


1	NAMES OF REPORTING PERSONS: James F. Dicke III

	I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY):


2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS):
	(a) o
	(b) þ

3	SEC USE ONLY:



4	CITIZENSHIP OR PLACE OF ORGANIZATION:

	The United States of America

		5	SOLE VOTING POWER:

NUMBER OF			66,275,000

SHARES		6	SHARED VOTING POWER:
BENEFICIALLY
OWNED BY			0

EACH		7	SOLE DISPOSITIVE POWER:
REPORTING
PERSON			66,275,000

WITH:		8	SHARED DISPOSITIVE POWER:

			0

9	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON:

	66,275,000

10	CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*:

	o

11	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9):

	9.4%

12	TYPE OF REPORTING PERSON (SEE INSTRUCTIONS):

	IN

*SEE INSTRUCTIONS BEFORE FILLING OUT!


CUSIP No.		007928104		Page 3 of 5 Pages


Item 1.

	(a)	Name of Issuer:

		Advanced Viral Research Corp.

	(b)	Address of Issuer’s Principal Executive Offices:

		200 Corporate Boulevard South
		Yonkers, New York 10107

Item 2.

	(a)	Name of Person Filing:

		James F. Dicke III

	(b)	Address of Principal Business Office:

		c/o Crown Equipment Corporation
		44 South Washington Street
		New Bremen, Ohio 45869

	(c)	Citizenship:

		The United States of America

	(d)	Title of Class of Securities:

		Common Shares

	(e)	CUSIP Number:

		007928104

Item 3.	Rules 13d-1(b) or 13d-2(b) or (c) Statement.

	Not applicable.

Item 4.	Ownership.

	(a)	Amount Beneficially Owned:

		66,275,000


CUSIP No.		007928104		Page 4 of 5 Pages


	(b)	Percent of Class:

		9.4%

	(c)	Number of shares as to which such person has:

		(i)	sole power to vote or to direct the vote:

			66,275,000

		(ii)	shared power to vote or to direct the vote:

			None.

		(iii)	sole power to dispose or to direct the disposition of:

			66,275,000

		(iv)	shared power to dispose or to direct the disposition of:

			None.

Item 5.	Ownership of Five Percent or Less of a Class.

	If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following o.

Item 6.	Ownership of More than Five Percent on Behalf of Another Person.

	Not applicable.

Item 7.	Identification and Classification of the Subsidiary which Acquired the Security Being Reported on by the Parent Holding Company.

	Not applicable.


CUSIP No.		007928104		Page 5 of 5 Pages


Item 8.		Identification and Classification of Members of the Group.

		In lieu of filing an exhibit to this Schedule 13G providing the identification and classification of the members of the group, such information is provided below.

		Name: James F. Dicke II
		Classification: IN

Item 9.		Notice of Dissolution of Group.

		Not applicable.

Item 10.		Certification.

By signing below, I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

Signature.

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Date: February 14, 2006


	JAMES F. DICKE III
	By	/s/ J. Michael Herr
		J. Michael Herr
		Attorney-in-fact for James F. Dicke III pursuant to Power of Attorney